A number of TikTok videos already swear by retatrutide, nicknamed “Reta”, presented as the miracle injection that would melt away the pounds when Wegovy or Zepbound peak. On Reddit and bodybuilding forums, testimonies of spectacular weight loss follow one another, relayed thousands of times. The promise is a dream. Problem: it’s not supposed to be accessible to almost anyone.
In reality, this triple agonist remains an experimental drug, not approved by the FDA or available in pharmacies. Eli Lilly told CNBC that it wants to submit its authorization request in the first quarter of 2027 for its weekly injection of retatrutide. So, how can we explain this impression that everyone already has it?
Retatrutide, the triple agonist that is shaking up trial results
Retatrutide belongs to the new wave of obesity treatments that target several hormones at once: GLP-1, GIP and glucagon, hence its nickname “triple G” drug. explains Rekha Kumar, cited by NewBeauty, who emphasizes that this multi-receptor mechanism distinguishes it from current injections.
The first phase 3 trials have fueled the buzz. In obese adults with type 2 diabetes, treated patients lost up to 20.8% of their weight, or nearly 50 pounds (about 22.7 kg) in 80 weeks. In people with severe obesity and cardiovascular disease, the average loss reached 22.6%, or 55.8 pounds, over the same duration, according to data reported to CNBC.
A drug still under review: real schedule of retatrutide
When she talks about it in the podcast, Rekha Kumar reminds us that the product has not yet passed the regulatory stage. she specifies, before adding: . Until this process is completed, retatrutide officially remains in the clinical trial stage.
This status has a direct consequence on what we really know about the product. insists Rekha Kumar. At the same time, Eli Lilly says it still needs time to verify its manufacturing and quality control data before even submitting its application in 2027, now presented as the next big step.
Between clinical trials and the gray market: who really takes retatrutide?
Officially, only volunteers included in phase 3 studies have access, under strict criteria and close monitoring. Outside of this framework, retatrutide is classified as a research peptide, reserved for laboratories and not suitable for human or animal use, as recalled in an analysis published by Presse Agence. On the gray market, however, bottles circulate online; however, warns Rekha Kumar, who adds: .
On TikTok or Reddit, a few hundred testimonials from clinical trials, bodybuilders or purchases of peptides labeled “for research use only” nevertheless create the illusion of massive use. For Rekha Kumar, the problem goes beyond this single medication: she says, before recalling: . And it sums up the limit of this quest for quick solutions: .
Is retatrutide available in pharmacies or in France?
No. Retatrutide remains an experimental drug, not approved by the FDA, without authorization in Europe and accessible only in supervised clinical trials.
Why does it seem like everyone is taking retatrutide?
Social networks amplify some spectacular testimonials and niche conversations, which gives the false impression of widespread use while legal access remains ultra limited.
What are the vials of retatrutide sold as research peptides worth?
These products are theoretically reserved for the laboratory, not for humans. Their identity, purity and sterility are not guaranteed, with a risk of contamination or random dosage.
When does Eli Lilly plan to seek approval for retatrutide?
Eli Lilly told CNBC that it is aiming to file with the FDA in the first quarter of 2027, with no specific approval timetable behind it.
Do retatrutide or other peptides replace healthy living?
No. As Rekha Kumar points out, these peptides are at best an additional aid and do not replace a suitable diet, physical activity, sleep or overall medical care.
